Growing community of inventors

Roquefort les Pins, France

Xavier Préville

Average Co-Inventor Count = 6.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Xavier PrévilleDaniel Olive (2 patents)Xavier PrévilleMarc Lopez (2 patents)Xavier PrévilleBenoit Joseph (1 patent)Xavier PrévilleGuy Fournet (1 patent)Xavier PrévilleJacobus Petrus Maria Elands (1 patent)Xavier PrévilleWarren Viricel (1 patent)Xavier PrévilleJack Elands (1 patent)Xavier PrévilleFlorence Lhospice (1 patent)Xavier PrévilleFlorence L'Hospice (1 patent)Xavier PrévilleJoanna Fares (1 patent)Xavier PrévilleXavier Préville (2 patents)Daniel OliveDaniel Olive (28 patents)Marc LopezMarc Lopez (8 patents)Benoit JosephBenoit Joseph (3 patents)Guy FournetGuy Fournet (2 patents)Jacobus Petrus Maria ElandsJacobus Petrus Maria Elands (1 patent)Warren ViricelWarren Viricel (1 patent)Jack ElandsJack Elands (1 patent)Florence LhospiceFlorence Lhospice (1 patent)Florence L'HospiceFlorence L'Hospice (1 patent)Joanna FaresJoanna Fares (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Université´ D'aix-Marseille (2 from 228 patents)

2. Institut Jean Paoli & Irène Calmettes (2 from 26 patents)

3. Centre National De La Recherche Scientifique (1 from 5,069 patents)

4. Eli Lilly and Company (1 from 4,442 patents)

5. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)

6. Universite Claude Bernard – Lyon1 (1 from 208 patents)

7. Centre National De La Recherche Scientifique-cnrs (1 from 65 patents)

8. Inserm (institut National De La Sante Et De La Recherche Medicale) (1 from 36 patents)

9. Mablink Bioscience (1 from 1 patent)

10. Emergence Therapeutics Gmbh (1 from 1 patent)


2 patents:

1. 12419964 - Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload

2. 12049500 - Anti-nectin-4-antibodies and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…